Old Web
English
Sign In
Acemap
>
authorDetail
>
W.S. Aronstein
W.S. Aronstein
Procter & Gamble
Medicine
Overactive bladder
Urology
Darifenacin
health related quality of life
2
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
S49 C-reactive protein as a biomarker for improved efficacy of lenzilumab in Covid-19 patients: results from the LIVE-AIR trial
2021
Thorax
Zelalem Temesgen
Charles D. Burger
Jason V. Baker
Christopher Polk
Claudia R. Libertin
Colleen F. Kelley
Vincent C. Marconi
Robert Orenstein
V. M. Catterson
W.S. Aronstein
Cameron Durrant
Dale Chappell
Omar J. Ahmed
Gabrielle Chappell
Andrew D. Badley
Show All
Source
Cite
Save
Citations (0)
MP-10.09: The effect of darifenacin on health-related quality of life in patients with overactive bladder: results from the ABLE study
2007
Urology
Michael B. Chancellor
W.S. Aronstein
M. Egermark
R. Ariely
Ursula Ebinger
F. Kianifard
Show All
Source
Cite
Save
Citations (2)
1